doi: 10.3945/jn.111.155259 64
Semaglutide and tirzepatide help with glycemic control and insulin sensitivity, which is especially beneficial for individuals with prediabetes, polycystic ovary syndrome (PCOS), or other conditions that may increase insulin resistance
The 4-day dietary recalls were evaluated with the Food Processor dietary assessment software program (ESHA Research, Salem, OR) to determine the average daily amount of kilocalories and macronutrient consumption of fat, carbohydrate, and protein in the diet at three different time points during the study
What results can patients expect after taking GLP-1 medications
Frier Levitt regulatory attorneys experienced in FDA law and pharmacy law are available to assist clients with strategic advisory, regulatory compliance and enforcement defense services in the GLP-1, compounded drug and peptide space as regulations and enforcement in this sector continues to evolve